Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach
Arunkumar Rengaraj†
a,
Balaji Subbiah†b,
Yuvaraj Haldoraic,
Dhanusha Yesudhasd,
Hyung Joong Yune,
Soonjo Kwonf,
Sangdun Choid,
Young-Kyu Hanc,
Eung-Soo Kima,
Hema Shenpagam N.*b and
Yun Suk Huh*a
aDepartment of Biological Engineering, Biohybrid Systems Research Center (BSRC), Inha University, Incheon, 22212, Republic of Korea. E-mail: yunsuk.huh@inha.ac.kr; Fax: +82-32-872-4046
bPG & Research Department of Microbiology, Hindustan College of Arts and Science, Coimbatore, 641028, India. E-mail: nhema10@yahoo.co.in
cDepartment of Energy and Materials Engineering, Dongguk University, Seoul, 100-715, Republic of Korea
dDepartment of Molecular Science and Technology, Ajou University, Suwon, 443-749, Republic of Korea
eAdvanced Nano Surface Research Group, Korea Basic Science Institute (KBSI), Republic of Korea
fDepartment of Biological Engineering, Integrated Tissue Engineering, Inha University, Incheon, 22212, Republic of Korea
First published on 13th February 2017
Abstract
Correction for ‘PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach’ by Arunkumar Rengaraj et al., RSC Adv., 2017, 7, 5046–5054.
A link to the equal contribution footnote, confirming that Arunkumar Rengaraj and Balaji Subbiah contributed equally to the work, is missing from the name of the second author in the published article. This is corrected herein.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
Footnote |
| † These authors contributed equally to this work. |
| This journal is © The Royal Society of Chemistry 2017 |